|
|
|
|
A more recent version of this article appeared on March 1, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 13, 2004
Accepted on December 13, 2004
Department of Cell Biology, Harvard Medical School, Boston MA 02115
Monitoring Editor: Mark Solomon
The Aurora family kinases contribute to accurate progression through several mitotic events. ZM447439 ("ZM"), the first Aurora family kinase inhibitor to be developed and characterized, was previously found to interfere with the mitotic spindle integrity checkpoint and chromosome segregation. Here, we have used extracts of Xenopus eggs, which normally proceed through the early embryonic cell cycles in the absence of functional checkpoints, to distinguish between ZMs effects on the basic cell cycle machinery and its effects on checkpoints. ZM clearly had no effect on either the kinetics or amplitude in the oscillations of activity of several key cell cycle regulators. It did, however, have striking effects on chromosome morphology. In the presence of ZM, chromosome condensation began on schedule but then failed to progress properly; instead, the chromosomes underwent premature decondensation during midmitosis. ZM strongly interfered with mitotic spindle assembly by inhibiting the formation of microtubules that are nucleated/stabilized by chromatin. By contrast, ZM had little effect on the assembly of microtubules by centrosomes at the spindle poles. Finally, under conditions where the spindle integrity checkpoint was experimentally induced, ZM blocked the establishment, but not the maintenance, of the checkpoint, at a point upstream of the checkpoint protein Mad2. These results show that Aurora kinase activity is required to ensure the maintenance of condensed chromosomes, the generation of chromosome-induced spindle microtubules, and activation of the spindle integrity checkpoint.
This article has been cited by other articles:
![]() |
C. Slawson, T. Lakshmanan, S. Knapp, and G. W. Hart A Mitotic GlcNAcylation/Phosphorylation Signaling Complex Alters the Posttranslational State of the Cytoskeletal Protein Vimentin Mol. Biol. Cell, October 1, 2008; 19(10): 4130 - 4140. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-H. Fu, W. Jiang, J.-T. Zheng, G.-Y. Zhao, Y. Li, H. Yi, Z.-R. Li, J.-D. Jiang, K.-Q. Yang, Y. Wang, et al. Jadomycin B, an Aurora-B kinase inhibitor discovered through virtual screening Mol. Cancer Ther., August 1, 2008; 7(8): 2386 - 2393. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Yamamoto, A. L. Lewellyn, and J. L. Maller Regulation of the Aurora B Chromosome Passenger Protein Complex during Oocyte Maturation in Xenopus laevis Mol. Cell. Biol., June 15, 2008; 28(12): 4196 - 4203. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Swain, J. Ding, J. Wu, and G. D. Smith Regulation of spindle and chromatin dynamics during early and late stages of oocyte maturation by aurora kinases Mol. Hum. Reprod., May 1, 2008; 14(5): 291 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Walsby, V. Walsh, C. Pepper, A. Burnett, and K. Mills Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts Haematologica, May 1, 2008; 93(5): 662 - 669. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Uzbekova, Y. Arlot-Bonnemains, J. Dupont, R. Dalbies-Tran, P. Papillier, S. Pennetier, A. Thelie, C. Perreau, P. Mermillod, C. Prigent, et al. Spatio-Temporal Expression Patterns of Aurora Kinases A, B, and C and Cytoplasmic Polyadenylation-Element-Binding Protein in Bovine Oocytes During Meiotic Maturation Biol Reprod, February 1, 2008; 78(2): 218 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, W. Lan, S. C. Ems-McClung, P. T. Stukenberg, and C. E. Walczak Aurora B Phosphorylates Multiple Sites on Mitotic Centromere-associated Kinesin to Spatially and Temporally Regulate Its Function Mol. Biol. Cell, September 1, 2007; 18(9): 3264 - 3276. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Manfredi, J. A. Ecsedy, K. A. Meetze, S. K. Balani, O. Burenkova, W. Chen, K. M. Galvin, K. M. Hoar, J. J. Huck, P. J. LeRoy, et al. Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase PNAS, March 6, 2007; 104(10): 4106 - 4111. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C.J. Vas, C. A. Andrews, K. Kirkland Matesky, and D. J. Clarke In Vivo Analysis of Chromosome Condensation in Saccharomyces cerevisiae Mol. Biol. Cell, February 1, 2007; 18(2): 557 - 568. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Girdler, K. E. Gascoigne, P. A. Eyers, S. Hartmuth, C. Crafter, K. M. Foote, N. J. Keen, and S. S. Taylor Validating Aurora B as an anti-cancer drug target J. Cell Sci., September 1, 2006; 119(17): 3664 - 3675. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Soncini, P. Carpinelli, L. Gianellini, D. Fancelli, P. Vianello, L. Rusconi, P. Storici, P. Zugnoni, E. Pesenti, V. Croci, et al. PHA-680632, a Novel Aurora Kinase Inhibitor with Potent Antitumoral Activity. Clin. Cancer Res., July 1, 2006; 12(13): 4080 - 4089. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Liu and J. V. Ruderman Aurora A, mitotic entry, and spindle bipolarity PNAS, April 11, 2006; 103(15): 5811 - 5816. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Ellis Functional Analysis of the Breast Cancer Genome J. Clin. Oncol., April 10, 2006; 24(11): 1649 - 1650. [Full Text] [PDF] |
||||
![]() |
B. B. Gadea and J. V. Ruderman Aurora B is required for mitotic chromatin-induced phosphorylation of Op18/Stathmin PNAS, March 21, 2006; 103(12): 4493 - 4498. [Abstract] [Full Text] [PDF] |
||||